Pure Global

Soft-tissue biopsy needle, single-use

Access comprehensive regulatory information for Soft-tissue biopsy needle, single-use in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Bard Australia Pty Ltd, manufactured by Angiomed GmbH & Co Medizintechnik KG in Germany. The device registration started on May 23, 2011.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIa
Class IIa
Soft-tissue biopsy needle, single-use
Australia TGA ARTG Registered Device
Good Name: Bard Australia Pty Ltd - Soft-tissue biopsy needle, single-use
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

Intended for percutaneous punctures into organs, tissues and vessels to obtain samples for cytology, also intended for percutaneous punctures for the introduction of guide wires.

Device Classification
Risk Class
Class IIa
Product Type
Single Device Product
ARTG Category
General
Registration Information
Start Date
May 23, 2011
Effective Date
May 23, 2011
Sponsor
Manufacturer
Country
Germany
Address
Wachhausstrasse 6, KARLSRUHE, 76227